20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings

TG Rhee, M Olfson, AA Nierenberg… - American Journal of …, 2020 - Am Psychiatric Assoc
Objective: Pharmacological options for treating bipolar disorder have increased over the
past 20 years, with several second-generation antipsychotics receiving regulatory approval …

[HTML][HTML] Efficacy, tolerability, and safety of toludesvenlafaxine for the treatment of major depressive disorder—A narrative review

O Vasiliu - Pharmaceuticals, 2023 - mdpi.com
The estimated rate of treatment-resistant major depressive disorder (TRD) remains higher
than 30%, even after the discovery of multiple classes of antidepressants in the last 7 …

A new paradigm for achieving a rapid antidepressant response

GS Malhi, G Morris, E Bell, A Hamilton - Drugs, 2020 - Springer
Abstract The substantive delay (often 4–6 weeks) between the commencement of an
antidepressant and any discernible improvement in depressive symptoms is an ongoing …

[HTML][HTML] Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia

HH Stassen, S Bachmann, R Bridler… - European archives of …, 2022 - Springer
Current treatment standards in psychiatry are oriented towards polypharmacy, that is,
patients receive combinations of several antidepressants, antipsychotics, mood stabilizers …

[HTML][HTML] Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders

J Wolff, P Reißner, G Hefner, C Normann, K Kaier… - PLoS …, 2021 - journals.plos.org
Introduction The aim of this study was to describe the number and type of drugs used to treat
depressive disorders in inpatient psychiatry and to analyse the determinants of potential …

Rising rates of suicidal behaviors and large unmet treatment needs among US adults with a major depressive episode, 2009 to 2020

TJ Bommersbach, RA Rosenheck, TG Rhee - Mayo Clinic Proceedings, 2023 - Elsevier
Objective To examine recent 12-year trends in the incidence of suicidal ideation (SI) and
suicide attempts (SAs) and receipt of mental health treatment among individuals …

Association of depression with 10-year and lifetime cardiovascular disease risk among US adults, national health and nutrition examination survey, 2005–2018

SD Barger, GC Struve - Preventing Chronic Disease, 2022 - stacks.cdc.gov
Introduction Although an association between depression and incident cardiovascular
disease (CVD) risk has been established, no US studies have quantified this association …

Comparison of potential psychiatric drug interactions in six drug interaction database programs: a replication study after 2 years of updates

S Monteith, T Glenn - Human Psychopharmacology: Clinical …, 2021 - Wiley Online Library
Objective Drug interaction database programs are a fundamental clinical tool. In 2018, we
compared the category of potential drug–drug interaction (DDI) provided by six drug …

Time trends in pharmacological treatment of major depressive disorder: results from the AMSP Pharmacovigilance Program from 2001–2017

J Seifert, RR Engel, X Bernegger, F Führmann… - Journal of Affective …, 2021 - Elsevier
Background: Currently available data on the prescription practice among patients with major
depressive disorder (MDD) reflect the outpatient setting. This is the first study to provide …

Prevalence of treatment for depression among US adults who screen positive for depression, 2007-2016

TG Rhee, ST Wilkinson, DC Steffens… - JAMA …, 2020 - jamanetwork.com
Methods| We used 2007-2016 data from 5 waves of the National Health and Nutrition
Examination Survey (NHANES), administrated by the National Center for Health Statistics of …